The Future of TV Advertising Under RFK
Brought to you by TripleLift and Next In Media
Pharmaceutical advertising has long been one of the biggest cash cows for the TV industry—flooding airwaves with those familiar “ask your doctor” spots featuring happy retirees kayaking their way through life. But what happens if those ads suddenly disappear?
That’s the question tackled in a new report from TVREV Thought Leaders Circle member TripleLift, written by Next In Media’s Mike Shields, which explores the potential impact of a pharma ad ban on TV—an idea that just got a lot more real with Robert F. Kennedy Jr. now confirmed as Secretary of Health and Human Services. RFK Jr. has made it clear he supports banning direct-to-consumer (DTC) pharmaceutical ads on TV, a move that would upend billions in TV ad revenue at a time when the industry is already scrambling to reinvent itself.
A ban like this wouldn’t just be a headache for networks—it would fundamentally reshape TV ad economics, shake up pharma’s marketing playbook, and send ad dollars scrambling to new platforms. So how bad would it be? The new study lays out the numbers, and they aren’t pretty.
Download the full report today - it’s FREE
